Stock Analysis
- Hong Kong
- /
- Healthcare Services
- /
- SEHK:2120
Wenzhou Kangning Hospital Reports Full Year 2023 Earnings
Wenzhou Kangning Hospital (HKG:2120) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥1.60b (up 7.5% from FY 2022).
- Net income: CN¥85.9m (up from CN¥24.2m loss in FY 2022).
- Profit margin: 5.4% (up from net loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Wenzhou Kangning Hospital shares are down 8.0% from a week ago.
Risk Analysis
Before you take the next step you should know about the 1 warning sign for Wenzhou Kangning Hospital that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if Wenzhou Kangning Hospital might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:2120
Wenzhou Kangning Hospital
Operates a network of healthcare facilities in the People’s Republic of China.